Immunic, Inc. · NASDAQ:IMUX
Morgan Stanley reported a 5.20% stake in Immunic, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Nov 13, 2026
Morgan Stanley reported a 5.20% stake in Immunic, Inc., 704,244 shares, as a passive investor on Sep 30, 2026. Filed Nov 13, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 704,244
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 5.20% | 704,244 |
Source
Download original · View original at SEC
Related
- Immunic, Inc.
- Morgan Stanley
- Immunic, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Nov 16, 2026
- Schedule 13G/A · Aberdeen Group plc · Nov 2, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026